Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 2, 1998, Pages 97-102

  Farrow, Diana C ^h   Vaughan, Thomas L ^j   Hansten, Philip D ^a   Stanford, Janet L ^j   Risch, Harvey A ^b   Gammon, Marilie D ^c   Chow, Wong Ho ^d   Dubrow, Robert ^b   Ahsan, Habibul ^c   Mayne, Susan T ^b   Schoenberg, Janet B ^e   West, A Brian ^b,i   Rotterdam, Heidi ^f   Fraumeni Jr , Joseph F ^d   Blot, William J ^g  

^a UNIVERSITY OF WASHINGTON   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Pathology ^*  (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Cancer Epidemiology Services   (United States)

^f Office of Cancer Epidemiology ^*  (United States)

^g INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANACIN; ASCRIPTIN; DICLOFENAC; DIFLUNISAL; ETODOLAC; EXCEDRIN; FENOPROFEN; FENOPROFEN CALCIUM; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMATE SODIUM; MECLOFENAMIC ACID; NABUMETONE; NAPROXEN; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PHENYLBUTAZONE; PIROXICAM; SULINDAC; TOLMETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CARDIA CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SMOKING; STOMACH NEOPLASMS; UNITED STATES;

EID: 6844240876     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kune, G. A , Kune, S , and Watson, L F, Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res , 48, 4399-4404, 1988.
2. Reeves, M J., Newcomb, P. A., Trentham-Dietz, A., Storer, B. E., and Remington, P. L. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol. Biomark Prev., 5: 955-960. 1996.
3. Thun, M. J., Namboodiri, M M , and Heath, C. W , Jr. Aspirin use and reduced risk of fatal colon cancer N. Engl. J Med., 325 1593-1596, 1991
4. Rosenberg, L , Palmer, J. R., Zauber, A. G., Warshauer, M E., Stotley, P D , and Shapiro, S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J. Natl. Cancer Inst , 83: 355-358, 1991.
5. Suh, O., Mettlin, C., and Petrelli, N. J. Aspirin use, cancer, and polyps of the large bowel Cancer (Phila.), 72: 1171-1177, 1993
6. Thun, M. J., Namboodin, M. M., Calle, E. E., Flanders, W. D., and Heath, C. W., Jr Aspirin use and risk of fatal cancer. Cancer Res , 53: 1322-1327, 1993.
7. Peleg, I I., Maibach, H T, Brown, S H., and Wilcox, C M. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer. Arch. Intern. Med., 154: 394-399, 1994
8. Muscat, J. E., Stellman, S. D., and Wynder, E. L Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer (Phila), 74: 1847-1854, 1994.
9. Giovannucci, E., Rimm, E B., Stampfer, M. J., Colditz, G. A , Ascherio, A., and Willett, W. C Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med., 121, 241-246, 1994
10. Schreinemachers, D. M., and Everson, R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology, 5: 138-146, 1994.
11. Giovannucci, E., Egan, K. M , Hunter, D. J., Stampfer, J. J , Colditz, G. A., Willett, W. C., and Speizer, F E. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333: 609-614, 1995
12. Berkel, H J., Holcombe, R. F., Middlebrooks, M , and Kannan, K. Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev., 18: 205-217, 1996
13. Funkhouser, E. M., and Sharp, G B Aspirin and reduced risk of esophageal carcinoma. Cancer (Phila.), 76, 1116-1119, 1995.
14. Harris, R. E., Namboodin, K. K , and Farrar, W. B. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology, 7: 203-205, 1996.
15. Morgan G Non-steroidal anti-inflammatory drugs and the chemoprevention of colorectal and oesophageal cancers. Gut, 38: 646-648, 1996
16. Martinez, M E., McPherson, R S., Levin, B , and Annegers, J. F. Aspirin and other nonsteroidal anti-inflammatory drugs and risk of colorectal adenomatous polyps among endoscoped individuals. Cancer Epidemiol Biomark. Prev, 4: 703-707, 1995
17. Giardiello, F. M , Hamilton, S. R , Krush, A. J., Piantadosi, S , Hylind. L. M., Celano, P , Booker, S. V., Roberson, C R., and Offerhaus, J. A. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
18. Rubio, C. A. Antitumoral activity of indomethacin on experimental esophageal rumors. J Natl. Cancer Inst, 72: 705-707, 1984.
19. Rubio, C. A Further studies on the therapeutic effect of indomethacin on esophageal tumors. Cancer (Phila), 58: 1029-1031, 1986.
20. Gammon, M. D., Schoenberg, J. B., Ahsan, H., Risch, H A., Vaughan, T. L., Chow, W-H., Rotterdam, H., West, A. B , Dubrow, R., Stanford, J B., Mayne, S. T., Farrow, D. C., Niwa, S., Blot, W. J., and Fraumeni, J F. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst , 89, 1277-1284, 1997.
21. Chow, W-H , Blot, W J., Vaughan, T L , Risch, H A , Gammon, M D , Stanford, J. B., Dubrow, R., Schoenberg, J B., Mayne, S. T., Farrow, D. C , Ahsan, H , West, A. B , Rotterdam, H , Niwa, S , and Fraumeni, J. F., Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia J Natl Cancer Inst., in press, 1998.
22. Kabat, G. C., Ng, S K. C., and Wynder, E. L. Tobacco, alcohol intake, and diet in relation to adenocarcinoma of the esophagus and gastric cardia. Cancer Causes Control, 4 123-132, 1993.
23. Brown, L. M., Silverman, D. T., Pottern, L. M., Schoenberg, J. B., Greenberg, R S , Swanson, G. M., Liff, J M , Schwartz, A. G., Hayes, R B., Blot, W J., and Hoover, R. N. Adenocarcinoma of the esophagus and csophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors Cancer Causes Control, 5: 333-340, 1994
24. Vaughan, T. L , Davis, S , Kristal, A., and Thomas, D. B Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomark. Prev., 4: 85-92, 1995
25. PDR Physicians' Desk Reference for Nonprescription Drugs, 17th ed. Montvale, NJ. Medical Economics Company, 1996
26. Marnett, L J. Aspirin and the potential role of prostaglandins in colon cancer Cancer Res., 52: 5575-5589, 1992.
27. Shiff, S. J., Koutsos, M. I., Qiao, L., and Rigas, B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis Exp. Cell Res., 222: 179-188, 1996
28. Elder, D J., Hague, A., Hicks, D. J., and Paraskeva, C Differential growth inhibition by the aspirin metabolite sahcylate in human colorectal tumor cell lines enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines. Cancer Res., 56 2273-2276, 1996.
29. Δ716knockout mice by inhibition of cyclooxygenase 2 (COX-2) Cell, 87. 803-809, 1996.
30. Fu, S , Ramanujam, K S., Meltzer, S. J., and Wilson, K. T. Expression and localization of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus. Gastroenterology, 13: A516, 1997.
31. Zhuang, A., Vortmeyer, A. O., Mark, E J., Odze, R . Emmert-Buck, M R, Merino, M. J , Moon, H., Liotta, L. A., and Duray, P. H. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma Cancer Res., 56 1961-1964, 1996